MyWealthGrowth.com logo
HomeMutual Funds

Nippon India Pharma Fund

Nippon India Pharma Fund

Regular PlanGrowth Option

Fund Performance

Lumpsum

SIP

25.22

as on 03 Dec 2021

3 Years

Investment of ₹ 10,000 in this fund 3 Years back would be ₹ 19,648 today.

Invest Now

NAV Performance

Nippon India Pharma Fund performance graph for last 3 years
Performance of Nippon India Pharma Fund for last 3 Years

Fund Information

  • ₹ 299.223

    as on 03 Dec 2021
  • Regular - Growth

  • -

  • ₹ 5,000

  • ₹ 5,447 Cr.

    as on 03 Dec 2021
  • 1.95%

    since 31 May 2021
  • 02 Jan 2013

  • Equity - Sectoral/Thematic

  • S&P BSE Healthcare TRI

  • Nippon India Mutual Fund

    Show All Funds
  • Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges.

Highlights of this fund

Nippon India Pharma Fund is an Open-ended Equity Fund. The fund belongs to Sectoral/Thematic category, where the investment is done in predominantly in stocks that are listed on Stock Exchanges like the Bombay Stock Exchange (BSE) or the National Stock Exchange (NSE) in India as well as Global stock exchanges like the Dow Jones, London Stock Exchange or LSE etc. This fund was started on 02 Jan 2013. This fund is offered by one of the top AMC (Assets Management Company) Nippon India Mutual Fund. You can also view here all other Equity funds offered by Nippon India Mutual Fund.

Latest NAV of the fund is ₹ 299.223 as on 03 Dec 2021.

This fund has 8 years of track record. Since 31 May 2021 expense ratio of this fund is 1.95%. Ideally you shoulds compare this fund with the benchmark S&P BSE Healthcare TRI.

You can invest in this fund in SIP with the minimum investment of ₹ 100. Lumpsum invest is offered with minimum investment of ₹ 5,000.

Fund Objective

To generate consistent returns by investing in equity,equity related of fixed income securities of Pharma and other associated companies.

List of Fund Managers of Nippon India Pharma Fund

  • About Sailesh Raj Bhan

    Picture of Sailesh Raj BhanMr. Sailesh Raj Bhan has over 24 years of experience in Indian Equity Markets with over 15 years at Reliance Nippon Life Asset Management Limited in Fund Management. He manages the flagship diversified equity schemes like Reliance Multi Cap Fund (previously Reliance Equity Opportunities Fund) - a strategy with assets of over Rs10,000cr ($1.5bn) since its inception in March 2005 and Reliance Large Cap Fund (previously Reliance Top200 Fund) – with assets of over Rs13000cr (over $1.8bn) since its inception 2007. Sailesh also manages the Largest Pharma Sector Fund in India since its inception 15 years back in May 2004, in addition to managing Reliance Consumption Fund – a broad based Consumption Thematic product since 2004. He also advises on international mandates for some strategies for the last 5 years.

Riskometer : Risk associated with this fund

Investors understand that their principal will be at High Risk

Fund Return Comparison

Fund Name 1 Month 3 Months 6 Months 1 Year 2 Years 3 Years 5 Years 10 Years 1 Year 2 Years 3 Years 5 Years 10 Years
Category Best 3.20% 15.98% 38.30% 94.99% 70.45% 42.10% 33.56% 25.52% 80.32% 86.67% 61.80% 42.56% 27.63%
Category Average -2.91% 1.78% 10.93% 40.02% 26.80% 19.13% 15.69% 14.73% 28.18% 38.96% 28.59% 18.54% 15.35%
Nippon India Pharma Fund -0.53%₹ 9,947 -5.03%₹ 9,496 1.60%₹ 10,159 23.56%₹ 12,355 13.45%₹ 12,853 40.86%₹ 19,860 33.50%₹ 32,874 25.22%₹ 19,648 32.79%₹ 57,446 16.06%₹ 21,074 24.27%₹ 1,09,448 18.89%₹ 56,550 18.19%₹ 3,12,503
ICICI Prudential Technology Fund 1.29%₹ 10,128 7.07%₹ 10,706 38.30%₹ 13,830 81.48%₹ 18,147 73.25%₹ 16,344 70.45%₹ 29,095 86.67%₹ 49,014 42.10%₹ 28,720 61.80%₹ 82,358 33.56%₹ 42,564 42.56%₹ 1,67,966 25.52%₹ 97,325 27.63%₹ 5,20,723
Aditya Birla Sun Life Digital India Fund 3.20%₹ 10,319 7.53%₹ 10,752 32.80%₹ 13,279 76.72%₹ 17,671 67.08%₹ 16,001 62.04%₹ 26,290 76.59%₹ 45,764 40.47%₹ 27,745 56.95%₹ 77,775 33.00%₹ 41,680 40.33%₹ 1,59,613 22.92%₹ 78,932 26.53%₹ 4,90,718
Tata Digital India Fund 1.43%₹ 10,142 7.70%₹ 10,769 37.43%₹ 13,743 82.39%₹ 18,239 71.55%₹ 16,250 61.87%₹ 26,236 78.18%₹ 46,269 39.38%₹ 27,099 56.21%₹ 77,086 33.48%₹ 42,439 40.57%₹ 1,60,502 - -
Quant Infrastructure Fund 1.84%₹ 10,184 15.98%₹ 11,598 25.33%₹ 12,533 94.99%₹ 19,499 80.32%₹ 16,732 52.53%₹ 23,293 86.38%₹ 48,919 36.57%₹ 25,495 57.69%₹ 78,462 25.84%₹ 31,602 34.57%₹ 1,39,702 15.13%₹ 40,990 21.33%₹ 3,70,265
SBI Technology Opportunities Fund 1.67%₹ 10,166 5.57%₹ 10,557 34.36%₹ 13,436 72.70%₹ 17,269 65.04%₹ 15,888 54.37%₹ 23,858 68.64%₹ 43,263 36.52%₹ 25,465 50.97%₹ 72,353 29.33%₹ 36,239 36.77%₹ 1,47,054 - -

Portfolio Holdings

Portfolio holdings pattern of Nippon India Pharma Fund as on 07 Dec 2021 are listed below:

  • Equity Holdings:

    95.36%
  • Debt Holdings:

    0.00%
  • Others Holdings:

    4.64%

Top Sector Holdings of Nippon India Pharma Fund

Name of SectorHolding PercentageHolding Values in Crore
Pharmaceuticals 74.18% ₹ 3,895.93 Cr.
Hospital 15.76% ₹ 864.07 Cr.
Healthcare service providers 5.42% ₹ 282.56 Cr.
Others 4.64% -

Top Stock Holdings of Nippon India Pharma Fund

Name of StocksHolding PercentageHolding Values in Crore
Sun Pharmaceutical Industries Ltd. 11.60% ₹ 604.28 Cr.
Dr. Reddys Laboratories Ltd. 9.39% ₹ 489.22 Cr.
Divis Laboratories Ltd. 7.91% ₹ 412.01 Cr.
Cipla Ltd. 7.82% ₹ 407.27 Cr.
Aurobindo Pharma Ltd. 7.28% ₹ 379.14 Cr.
Others 56.00% -

Other Holdings

Holding TypeHolding Percentage
TREPS 4.90%
Margin 0.18%
Net Receivables -0.44%